Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03824197 · ClinicalTrials.gov registry record · NA
Auburn University Research on Olive Oil for Alzheimer's Disease (AU-ROOAD)
A NA study, sponsored by Auburn University.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT03824197 is a NA study that has completed, run by Auburn University. The registered enrollment target is 25 participants.
The verdict
NCT03824197, a NA study, has completed, sponsored by Auburn University.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
Until now there is no medical treatment and/or intervention that can slow, stop or reverse the underlying neurodegenerative of Alzheimer's disease (AD). The goal of this study is to demonstrate "Oleocanthal rich-extra-virgin olive oil (EVOO) consumption stops or delay mild cognitive impairment conversion to AD by restoring the blood-brain barrier (BBB) function in humans". Specific Aims: 1. Evaluate effect of EVOO on the brain function by functional MRI (fMRI) imaging, and BBB function by dynamic contrast-enhanced MRI (DCE-MRI). 2. Evaluate effect of EVOO on cognitive function and on selected biomarkers
Interventions
- OTHER EVOO
- OTHER OO
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2019-05-07 |
| Est. Completion | 2020-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03824197
The ClinicalTrials.gov registry entry for NCT03824197 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Auburn University, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which EVOO is the first listed.
NCT03824197 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03824197 about?
NCT03824197 is a clinical study titled "Auburn University Research on Olive Oil for Alzheimer's Disease (AU-ROOAD)". Until now there is no medical treatment and/or intervention that can slow, stop or reverse the underlying neurodegenerative of Alzheimer's disease (AD). The goal of this study is to demonstrate "Oleocanthal rich-extra-virgin olive oil (EVOO) consumption stops or delay mild cognitive impairment conve...
What is the current status of trial NCT03824197?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2019-05-07. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT03824197?
The interventions under investigation include: EVOO (OTHER), OO (OTHER).
Who is sponsoring clinical trial NCT03824197?
This trial is sponsored by Auburn University, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.